Triple-combo drug shows promise against antiviral-resistant H1N1, UAB researcher says

October 27, 2009

BIRMINGHAM, Ala. - An experimental drug cocktail that includes three previously approved drugs offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.

In laboratory testing, the triple combination of oseltamivir (Tamiflu), amantadine (Symmetrel) and ribavirin showed a significant capacity to stop flu-virus growth, says Mark Prichard, Ph.D, who serves on the board of directors of the International Society for Antiviral Research. The combo drug works better in the test tube than currently recommended single or double antiviral therapies used to treat both seasonal and swine flu strains, he says.

Prichard presented his data in September at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy held in San Francisco. The triple-combo testing is led by Adamas Pharmaceuticals, Inc. based in Emeryville, California.

"These findings suggest strongly that the triple combo is highly synergistic against virus replication, meaning it strikes multiple targets within H1N1 flu and other strains," Prichard says. "Only human testing will determine for sure, but this combo has the potential to be the antiviral therapy of choice for serious flu infection and to address Tamiflu resistance."

The synergy was seen in swine flu and seasonal flu strains, as well as H3N2 seasonal flu and the highly pathogenic H5N1 avian influenza strain, Prichard says. The dosing and timing of the combo mixture is protected information by Adamas. The company is starting human testing in the Southern Hemisphere, and has plans to begin human testing in North America once approval is obtained.

Because flu infection typically lasts for shorter periods of time than many other chronic infections, the three-pronged antiviral approach means the circulating strains of flu virus may not have time to develop resistance to the combo, Prichard says. "That's why this research is so timely, and why antiviral safety and testing data is crucial.

"If this triple combo could reduce the impact to families and the healthcare system that comes from serious flu cases, we would be thrilled."
-end-
The testing is partnership between UAB, Adamas, the United States Naval Health Research Center in San Diego, Utah State University in Logan, and the Amsterdam Medical Center in the Netherlands.

About Adamas Pharmaceuticals

Adamas is an emerging pharmaceutical company focused on developing small molecule, advantaged therapeutics to treat neurological and infectious diseases, including influenza A, the cause of the current flu pandemic. Adamas' approach to pharmaceutical development is to identify synergistic drug mechanisms that can be developed as optimized combination drug therapies to increase safety, efficacy and compliance, thus improving upon the standard of care.

About UAB

UAB is the state of Alabama's largest employer and an internationally renowned research university and academic health center whose professional schools and specialty patient care programs are consistently ranked as among the nation's top 50. The UAB Health System includes all of the University of Alabama at Birmingham's patient care activities, including UAB Hospital, the Callahan Eye Foundation Hospital and The Kirklin Clinic. Find more information at www.uab.edu and www.uabmedicine.org.

University of Alabama at Birmingham

Related Swine Flu Articles from Brightsurf:

Swine flu vaccination in pregnant women did not increase risk of autism in offspring
Two recent studies were unable to rule out that H1N1 ('swine flu') vaccination ('Pandemrix') and seasonal influenza vaccination given to pregnant women might be associated with autism-spectrum disorder in the offspring.

Flu, flu-like illnesses linked to increased risk of stroke, neck artery tears
Flu-like illnesses are associated with an increased risk of stroke and neck artery dissection.

ID'ing features of flu virus genome may help target surveillance for pandemic flu
Researchers at Washington University School of Medicine in St. Louis have identified features of the influenza virus genome that affect how well the virus multiplies.

The risk of type 1 diabetes not increased by swine flu vaccine Pandemrix
There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy.

Yarraman flu or horse flu? Words and graphics influence willingness to vaccinate
'Yarraman flu is a virus quickly infecting the US...' The mock announcement was enough to make readers worry.

Flu nasal spray provides similar protection against influenza as flu shot: Study
For the study, the research team conducted a three-year trial in a Hutterite colony, where people live communally and are relatively isolated from cities and towns, to determine whether vaccinating children and adolescents with the flu nasal spray provided better direct and community protection than the standard flu shot.

Researchers discover the 2009 swine flu pandemic originated in Mexico
The 2009 swine H1N1 flu pandemic -- responsible for more than 17,000 deaths worldwide -- originated in pigs from a very small region in central Mexico, a research team headed by investigators at the Icahn School of Medicine at Mount Sinai is reporting.

Threat of novel swine flu viruses in pigs and humans
The wide diversity of flu in pigs across multiple continents, mostly introduced from humans, highlights the significant potential of new swine flu strains emerging, according to a study to be published in eLife.

Simulation study shows that pandemic swine flu had a minor impact in Finland
Researchers have used modeling to estimate the true impact of infectious diseases, such as swine flu, when underreporting can mean the surveillance from time of the pandemic can miss the vast majority of infections that occur in the population.

Where flu vaccination rates are higher in adults under 65, lower flu risk for seniors
Healthy adults who get the flu vaccine may help protect not only themselves but also older adults in their community at higher risk for serious complications from influenza, suggest findings from a new study published in Clinical Infectious Diseases.

Read More: Swine Flu News and Swine Flu Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.